Sugi Predict

Sugi Predict / Compounds / Alanine

Alanine

Alanine

SCHEMBL452350

CC(N)C(=O)O.C[C@H](N)C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 2/20 0.59
▸ TP53 P04637 1/20 0.53
▸ SLC1A3 P43003 2/20 0.43
▸ SLC1A2 P43004 2/20 0.43
▸ SLC1A1 P43005 1/20 0.43
▸ GABRP O00591 4/20 0.43
▸ GABRD O14764 4/20 0.43
▸ GABRA1 P14867 4/20 0.43
▸ GABRB1 P18505 4/20 0.43
▸ GABRG2 P18507 4/20 0.43
▸ GABRB3 P28472 4/20 0.43
▸ GABRA5 P31644 4/20 0.43
▸ GABRA3 P34903 4/20 0.43
▸ GABRA2 P47869 4/20 0.43
▸ GABRB2 P47870 4/20 0.43
▸ GABRA4 P48169 4/20 0.43
▸ GABRE P78334 4/20 0.43
▸ GABRA6 Q16445 4/20 0.43
▸ GABRG1 Q8N1C3 4/20 0.43
▸ GABRG3 Q99928 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Alanine SCHEMBL43623 1.00 — —
D-Alanine SCHEMBL614024 1.00 SLC7A5 (0.59) SLC7A5TP53SLC1A3SLC1A2SLC1A1
Alanine SCHEMBL10723495 1.00 SLC7A5 (0.59) SLC7A5TP53SLC1A3SLC1A2SLC1A1
Alanine SCHEMBL1332110 1.00 — —
Alanine SCHEMBL31 1.00 — —
Alanine SCHEMBL254290 1.00 SLC7A5 (0.59) SLC7A5TP53SLC1A3SLC1A2SLC1A1
Alanine SCHEMBL2784274 1.00 — —
Alanine SCHEMBL14764702 1.00 SLC7A5 (0.59) SLC7A5TP53SLC1A3SLC1A2SLC1A1
D-Alanine SCHEMBL2027760 1.00 SLC7A5 (0.59) SLC7A5TP53SLC1A3SLC1A2SLC1A1
D-Alanine SCHEMBL31040666 1.00 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116694539-B Lactobacillus plantarum J26 as direct vat set starter, and preparation method and application thereof 东北农业大学 2023-11-17 — — CN disclosed
US-10471149-B2 Stabilized vancomycin formulations INSMED INCORPORATED (US) 2019-11-12 — — US disclosed
EP-2925298-B1 STABILIZED VANCOMYCIN FORMULATIONS INSMED INC (US) 2019-05-29 — — EP disclosed
US-20190022232-A1 STABILIZED VANCOMYCIN FORMULATIONS INSMED INCORPORATED 2019-01-24 — — US disclosed
US-10124066-B2 Stabilized vancomycin formulations INSMED INCORPORATED (US) 2018-11-13 — — US disclosed
US-20150314002-A1 STABILIZED VANCOMYCIN FORMULATIONS INSMED INCORPORATED 2015-11-05 — — US disclosed
US-8269037-B2 Absorption medium for removing acid gases which comprises amino acid and acid promoter BASF SE (DE) 2012-09-18 — — US disclosed
EP-2449488-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES Life Sciences AG (AT) 2012-05-09 — — EP disclosed
US-20120051989-A1 REMOVAL OF ACID GASES FROM A FLUID FLOW BY MEANS OF REDUCED COABSORPTION OF HYDROCARBONS AND OXYGEN BASF SE (DE) 2012-03-01 — — US disclosed
US-8034166-B2 Carbon dioxide absorbent requiring less regeneration energy BASF SE (DE) 2011-10-11 — — US disclosed
WO-1998046631-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC MACROCYCLES AND PROCESSES THEREFOR ELI LILLY AND COMPANY (US) 1998-10-22 — — WO disclosed
WO-1998046786-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC AMINOTHIOETHER ACIDS ELI LILLY AND COMPANY (US) 1998-10-22 — — WO disclosed
US-5478733-A Culture product KYOWA HAKKO KOGYO CO., LTD. (JP) 1995-12-26 — — US disclosed
US-5403579-A A mouthwashes consisting of a higher alkyl-N-sulfobetaine and a higher alkyl dimethylamine oxide, dihydroxyethylamine oxide or acylamide tert-amine oxide; antibacteria, antiplague, antistaining E. B. MICHAELS RESEARCH ASSOCIATES, INC. (US) 1995-04-04 — — US disclosed
EP-0294391-B1 PROCESS AND COMPOSITION FOR ORAL HYGIENE MICHAELS E B RES ASS (US) 1994-02-02 — — EP disclosed
US-5275804-A Amphoteric surfactants as bactericides or fungicides for mouth washes E. B. MICHAELS RESEARCH ASSOCIATES, INC. (US) 1994-01-04 — — US disclosed
EP-0294391-A4 PROCESS AND COMPOSITION FOR ORAL HYGIENE — 1991-10-16 — — EP disclosed
US-4839158-A APPLYING MIXTURES OF HIGHER ALKYL N-BETAINE AND N,N-DIMETHYL AMINE OXIDE E. B. MICHAELS RESEARCH ASSOCIATES INC. (US) 1989-06-13 — — US disclosed
EP-0294391-A1 PROCESS AND COMPOSITION FOR ORAL HYGIENE. MICHAELS E B RES ASS INC (US) 1988-12-14 — — EP disclosed
WO-1987004922-A1 PROCESS AND COMPOSITION FOR ORAL HYGIENE E.B. MICHAELS RESEARCH ASSOCIATES, INC. (US) 1987-08-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10471149-B2 Stabilized vancomycin formulations CETP, PCSK9, HDLBP SLC7A5 1112/4885TP53 2076/4885SLC1A3 3544/4885
US-10124066-B2 Stabilized vancomycin formulations CETP, PCSK9, HDLBP SLC7A5 1112/4885TP53 2076/4885SLC1A3 3544/4885
US-20150314002-A1 STABILIZED VANCOMYCIN FORMULATIONS CETP, PCSK9, HDLBP SLC7A5 1112/4885TP53 2076/4885SLC1A3 3544/4885
US-20190022232-A1 STABILIZED VANCOMYCIN FORMULATIONS CETP, PCSK9, HDLBP SLC7A5 1112/4885TP53 2076/4885SLC1A3 3544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.